Blog

Medscape: Poor Screen, Sleep Hygiene Drying Out Kids’ Eyes

Protect Your Child’s Eyes from Screen Time Dryness In an age where digital devices are integral to both education and entertainment, our children’s eyes are working overtime. From online classes and homework to video games and social media, screens are an unavoidable part of modern childhood. While we often worry about the content they’re consuming, […]

Medscape: Poor Screen, Sleep Hygiene Drying Out Kids’ Eyes Read More »

Upper Eyelid Surgeries Offer Lasting QOL Benefits, May Not Worsen Dry Eye

Upper Eyelid Surgery Boosts Quality of Life Without Worsening Dry Eye For many, the thought of eyelid surgery, or blepharoplasty, conjures images of purely cosmetic enhancement. However, a significant number of people seek this procedure for functional reasons—to improve a sagging eyelid that obstructs vision. A common concern for both patients and surgeons has been

Upper Eyelid Surgeries Offer Lasting QOL Benefits, May Not Worsen Dry Eye Read More »

Acoltremon Improves Tear Production and Symptoms in Dry Eye Disease

Acoltremon Boosts Tear Production and Relieves Dry Eye Symptoms For millions of people around the world, the persistent discomfort of dry eye disease is a daily reality. Characterized by a stinging sensation, redness, blurred vision, and a feeling of grit in the eyes, this condition can significantly impact quality of life. While artificial tears and

Acoltremon Improves Tear Production and Symptoms in Dry Eye Disease Read More »

Ophthalmic Topical Therapeutics Market to Reach USD 48.3 Billion by 2034

Ophthalmic Therapeutics Market to Hit $48.3 Billion by 2034 The landscape of vision care is on the cusp of a monumental transformation. According to recent market analysis, the global ophthalmic therapeutics market is projected to surge, reaching a staggering valuation of $48.3 billion by the year 2034. This explosive growth underscores a critical global shift:

Ophthalmic Topical Therapeutics Market to Reach USD 48.3 Billion by 2034 Read More »

Eye implant reverses blindness in study co-led by Pitt researcher – Pittsburgh Post-Gazette

Pitt Research Breakthrough Reverses Blindness with New Eye Implant For millions of people living with retinal degenerative diseases, the world slowly fades to black. Conditions like age-related macular degeneration and retinitis pigmentosa rob individuals of their sight by causing the light-sensitive photoreceptor cells in the retina to die. While the rest of the eye’s circuitry

Eye implant reverses blindness in study co-led by Pitt researcher – Pittsburgh Post-Gazette Read More »

Beyond the surface: Tackling complex dry eye cases

Unmasking the Hidden Causes of Complex Dry Eye Disease For millions, dry eye disease is a constant, irritating companion. The hallmark symptoms—a persistent gritty or burning sensation, redness, and blurred vision—are all too familiar. Many of us reach for over-the-counter artificial tears, hoping for a quick fix. But what happens when the drops aren’t enough?

Beyond the surface: Tackling complex dry eye cases Read More »

Lilly bags eye-catching retinal disease gene therapy from MeiraGTx in $475M deal

Eli Lilly Bolsters Gene Therapy Pipeline with Strategic $475 Million MeiraGTx Acquisition In a significant move that underscores the growing importance of genetic medicine, pharmaceutical giant Eli Lilly has announced a definitive agreement to acquire MeiraGTx’s gene therapy program for a substantial $445 million upfront, with a potential total value reaching $475 million. This strategic

Lilly bags eye-catching retinal disease gene therapy from MeiraGTx in $475M deal Read More »

Lilly Doubles Down on Eye Diseases, Adding to BD Spree

Lilly Intensifies Eye Disease Focus in Strategic Acquisition Spree In a bold move that signals a significant expansion of its therapeutic horizons, Eli Lilly and Company is sharpening its focus on ophthalmology. The pharmaceutical giant, already riding a wave of success with its metabolic treatments, is now channeling its strategic momentum into the fight against

Lilly Doubles Down on Eye Diseases, Adding to BD Spree Read More »

Scroll to Top